Genome-wide association studies (GWASs) and experimental models [Multi-Center Cohort, N = 1161], such as knockout and transgenic mice, have linked ApoA proteins to a spectrum of conditions, including stroke and neurodegenerative disorders like Alzheimer’s disease (AD) [23,24]. This evidence concerns the gene APOA1 and early-onset autosomal dominant Alzheimer disease.